Taken together, our results provide insights into the roles of gram-negative bacteria in gut-generated LPS and intracellular gram-negative bacterial infections in CKD and hyperlipidemia pathologies activating CASP4/11-GSDMD and IL1B pathways. The gene discussed is IL1B; the disease is hyperlipidemia.